PMCB vs RL · $8.6M cap vs P/E 24, rev $8.11B
PharmaCyte Biotech Inc (PMCB) versus Ralph Lauren Corp Class A (RL) — a side-by-side from cached financials, not a winner call.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
PMCB currently screens at market cap $8.6M. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Not investment advice. Open the PMCB and RL stock pages for the full models.
Not investment advice.